title: Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development.
abstract: From early in the HIV epidemic it was appreciated that many inflammatory markers such as neopterin and TNF-α were elevated in patients with AIDS. With the advent of modern technology able to measure a broad array of cytokines, we now know that from the earliest points of infection HIV induces a cytokine storm. This review will focus on how cytokines are disturbed in HIV infection and will explore potential therapeutic uses of cytokines. These factors can be used directly as therapy during HIV infection, either to suppress viral replication or prevent deleterious immune effects of infection, such as CD4+ T cell depletion. Cytokines also show great promise as adjuvants in the development of HIV vaccines, which would be critical for the eventual control of the epidemic.
authors: Blood Systems Research Institute, 270 Masonic Avenue, San Francisco, CA 94118, USA. skeating@bloodsystems.org
authors: Sheila M
authors: SM
authors: Keating
authors: Evan S
authors: ES
authors: Jacobs
authors: Philip J
authors: PJ
authors: Norris
mesh_terms: D016915:AIDS Vaccines / Q000276:immunology*; D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000378:metabolism / Q000517:prevention & control; D000818:Animals; D016207:Cytokines / Q000097:blood / Q000276:immunology* / Q000627:therapeutic use; D015658:HIV Infections / Q000276:immunology* / Q000517:prevention & control / Q000821:virology; D015497:HIV-1 / Q000187:drug effects / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D018836:Inflammation Mediators / Q000097:blood / Q000276:immunology* / Q000627:therapeutic use
chemical_list: D016915:AIDS Vaccines; D016207:Cytokines; D018836:Inflammation Mediators